Chiron
This article was originally published in The Gray Sheet
Executive Summary
Company confirms on Nov. 11 that it is in "discussions with another company regarding a potential strategic alliance that would include the other company acquiring a very substantial minority equity investment in Chiron." Diagnostic and quantitative nucleic acid test manufacturer Chiron, based in Emeryville, California, stressed that "no agreement has been reached," and that "there is no assurance any transaction will result"